FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

442435002: Golimumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2009. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2820069013 Golimumab en Synonym Active Entire term case insensitive SNOMED CT core module
2820070014 Golimumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Golimumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Golimumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Golimumab Has disposition Tumor necrosis factor alpha inhibitor true Inferred relationship Existential restriction modifier
Golimumab Is a Substance with tumor necrosis factor alpha inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing golimumab Has active ingredient True Golimumab Inferred relationship Existential restriction modifier 1
Golimumab 50mg injection solution 0.5ml prefilled syringe Has active ingredient False Golimumab Inferred relationship Existential restriction modifier
Golimumab therapy Direct substance True Golimumab Inferred relationship Existential restriction modifier 2
Golimumab Has active ingredient True Golimumab Inferred relationship Existential restriction modifier 1
Product containing precisely golimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Golimumab Inferred relationship Existential restriction modifier 1
Product containing precisely golimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Golimumab Inferred relationship Existential restriction modifier 1
Product containing golimumab in parenteral dose form (medicinal product form) Has active ingredient True Golimumab Inferred relationship Existential restriction modifier 1
Product containing only golimumab in parenteral dose form (medicinal product form) Has active ingredient True Golimumab Inferred relationship Existential restriction modifier 1
Mass concentration of golimumab in serum (observable entity) Component True Golimumab Inferred relationship Existential restriction modifier 1
Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices Has active ingredient False Golimumab Inferred relationship Existential restriction modifier
Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Golimumab 50mg/0.5ml solution for injection pre-filled syringes Has active ingredient False Golimumab Inferred relationship Existential restriction modifier
Golimumab 50mg/0.5ml solution for injection pre-filled syringes Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 50mg/0.5ml solution for injection pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) Has active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 50mg/0.5ml solution for injection pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 50mg/0.5ml solution for injection pre-filled pens (Merck Sharp & Dohme (UK) Ltd) Has active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 50mg/0.5ml solution for injection pre-filled pens (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Golimumab 50mg/0.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 50mg/0.5ml solution for injection pre-filled syringes (Merck Sharp & Dohme (UK) Ltd) 1 pre-filled disposable injection Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 50mg/0.5ml solution for injection pre-filled pens (Merck Sharp & Dohme (UK) Ltd) 1 pre-filled disposable injection Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Golimumab 100mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Golimumab Inferred relationship Existential restriction modifier
Golimumab 100mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 100mg/1ml solution for injection pre-filled pens (Merck Sharp & Dohme (UK) Ltd) Has active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 100mg/1ml solution for injection pre-filled pens (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Golimumab 100mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier
Simponi 100mg/1ml solution for injection pre-filled pens (Merck Sharp & Dohme (UK) Ltd) 1 pre-filled disposable injection Has specific active ingredient True Golimumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start